Related references
Note: Only part of the references are listed.Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken et al.
LANCET ONCOLOGY (2013)
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2012)
Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
N. S. Horowitz et al.
GYNECOLOGIC ONCOLOGY (2012)
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
John Farley et al.
GYNECOLOGIC ONCOLOGY (2011)
Are We Making Progress in Curing Advanced Cervical Cancer?
Gillian Thomas
JOURNAL OF CLINICAL ONCOLOGY (2011)
Human Papillomaviruses As Therapeutic Targets in Human Cancer
Karin Hellner et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Alfonso Duenas-Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Daniel Herchenhorn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
D. D. Meira et al.
BRITISH JOURNAL OF CANCER (2009)
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
J. E. Kurtz et al.
GYNECOLOGIC ONCOLOGY (2009)
A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
Russell J. Schilder et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment
Tan Min Chin et al.
CLINICAL CANCER RESEARCH (2008)
Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer
Angelica Nogueira-Rodrigues et al.
CLINICAL CANCER RESEARCH (2008)
EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
Bhavna Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Human papillomavirus in cervical and head-and-neck cancer
Amanda Psyrri et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Is EGFR a moving target during radiotherapy of carcinoma of the uterine cervix?
Ferdinando Cerciello et al.
GYNECOLOGIC ONCOLOGY (2007)
EGFR-targeted anti-cancer drugs in radiotherapy:: Preclinical evaluation of mechanisms
Michael Baumann et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
Niklas Reimers et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivoi
MK Nyati et al.
CLINICAL CANCER RESEARCH (2004)
The epidermal growth factor receptor mediates radioresistance
K Liang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
R Pearcey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
